Search Results - "AMBROSE, Paul G"

Refine Results
  1. 1

    Pharmacodynamics of Tebipenem: New Options for Oral Treatment of Multidrug-Resistant Gram-Negative Infections by McEntee, Laura, Johnson, Adam, Farrington, Nicola, Unsworth, Jennifer, Dane, Aaron, Jain, Akash, Cotroneo, Nicole, Critchley, Ian, Melnick, David, Parr, Thomas, Ambrose, Paul G, Das, Shampa, Hope, William

    Published in Antimicrobial agents and chemotherapy (01-08-2019)
    “…Tebipenem pivoxil HBr (TBPM-PI-HBr) is a novel orally bioavailable carbapenem. The active moiety is tebipenem. Tebipenem pivoxil is licensed for use in Japan…”
    Get full text
    Journal Article
  2. 2

    Extended-Spectrum β-Lactamases and Clinical Outcomes: Current Data by Ramphal, Reuben, >, Paul G. Ambrose

    Published in Clinical infectious diseases (15-04-2006)
    “…Nosocomial infections caused by extended-spectrum β-lactamase (ESBL)—producing gram-negative bacteria complicate therapy and limit treatment options. However,…”
    Get full text
    Journal Article
  3. 3

    Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore by Ambrose, Paul G., Bhavnani, Sujata M., Rubino, Christopher M., Louie, Arnold, Gumbo, Tawanda, Forrest, Alan, Drusano, George L.

    Published in Clinical infectious diseases (01-01-2007)
    “…Since the advent of the modern era of antimicrobial chemotherapy in the 1930s, animal infection models have allowed for the in vivo evaluation of antimicrobial…”
    Get full text
    Journal Article
  4. 4

    Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis by Bhavnani, Sujata M., Rubino, Christopher M., Ambrose, Paul G., Drusano, George L.

    Published in Clinical infectious diseases (15-06-2010)
    “…Background. The objective of this analysis was to evaluate the relationship between daptomycin exposure and the probability of an elevation in the creatine…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Conserving antibiotics for the future: New ways to use old and new drugs from a pharmacokinetic and pharmacodynamic perspective by Mouton, Johan W, Ambrose, Paul G, Canton, Rafael, Drusano, George L, Harbarth, Stephan, MacGowan, Alasdair, Theuretzbacher, Ursula, Turnidge, John

    Published in Drug resistance updates (01-04-2011)
    “…Abstract There is a growing need to optimize the use of old and new antibiotics to treat serious as well as less serious infections. The topic of how to use…”
    Get full text
    Journal Article
  7. 7

    Antimicrobial Safety: Focus on Fluoroquinolones by Owens, Robert C., Ambrose, Paul G.

    Published in Clinical infectious diseases (15-07-2005)
    “…Background/purpose. Infrequent toxicities associated with certain drugs and drug classes have recently gained much attention from different health-care…”
    Get full text
    Journal Article
  8. 8

    Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations by Bhavnani, Sujata M, Ambrose, Paul G, Hammel, Jeffrey P, Rubino, Christopher M, Drusano, George L

    Published in Antimicrobial agents and chemotherapy (01-03-2016)
    “…The choice of an antimicrobial agent must balance optimization of efficacy endpoints with the minimization of safety events. The risk versus benefit of…”
    Get full text
    Journal Article
  9. 9

    Pharmacokinetic-Pharmacodynamic Considerations in the Design of Hospital-Acquired or Ventilator-Associated Bacterial Pneumonia Studies: Look before You Leap by Ambrose, Paul G., Bhavnani, Sujata M., Grosse, Evelyn J. Ellis, Drusano, George L.

    Published in Clinical infectious diseases (01-08-2010)
    “…Our thesis is a simple one: although a drug can fail in an individual patient for many reasons, appropriately sized and conducted drug-development programs…”
    Get full text
    Journal Article Conference Proceeding
  10. 10

    Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline by BHAVNANI, Sujata M, RUBINO, Christopher M, HAMMEL, Jeffrey P, FORREST, Alan, DARTOIS, Nathalie, COOPER, C. Angel, KORTH-BRADLEY, Joan, AMBROSE, Paul G

    Published in Antimicrobial Agents and Chemotherapy (01-02-2012)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  11. 11

    Use of Pharmacokinetic-Pharmacodynamic Analyses To Optimize Therapy with the Systemic Antifungal Micafungin for Invasive Candidiasis or Candidemia by ANDES, David, AMBROSE, Paul G, HAMMEL, Jeffrey P, VAN WART, Scott A, IYER, Varsha, REYNOLDS, Daniel K, BUELL, Donald N, KOVANDA, Laura L, BHAVNANI, Sujata M

    Published in Antimicrobial Agents and Chemotherapy (01-05-2011)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  12. 12
  13. 13

    The Pharmacokinetic and Pharmacodynamic Profile of Tigecycline by Meagher, Alison K., Ambrose, Paul G., Grasela, Thaddeus H., Grosse, J. Ellis

    Published in Clinical infectious diseases (01-09-2005)
    “…Tigecycline, a first-in-class expanded-spectrum antimicrobial agent, has demonstrated efficacy in the treatment of complicated intra-abdominal and skin and…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Pharmacological Basis of β-Lactamase Inhibitor Therapeutics: Tazobactam in Combination with Ceftolozane by VANSCOY, Brian, MENDES, Rodrigo E, AMBROSE, Paul G, MCCAULEY, Jennifer, BHAVNANI, Sujata M, BULIK, Catharine C, OKUSANYA, Olanrewaju O, FORREST, Alan, JONES, Ronald N, FRIEDRICH, Lawrence V, STEENBERGEN, Judith N

    Published in Antimicrobial Agents and Chemotherapy (01-12-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  16. 16

    Back to the Future: Using Aminoglycosides Again and How to Dose Them Optimally by Eliopoulos, George M., Drusano, George L., Ambrose, Paul G., Bhavnani, Sujata M., Bertino, Joseph S., Nafziger, Ann N., Louie, Arnold

    Published in Clinical infectious diseases (15-09-2007)
    “…Gram-negative organisms have become increasingly resistant to both β-lactam antibiotics and fluoroquinolones. Consequently, aminoglycoside antibiotics have…”
    Get full text
    Journal Article
  17. 17

    Isoniazid Bactericidal Activity and Resistance Emergence: Integrating Pharmacodynamics and Pharmacogenomics To Predict Efficacy in Different Ethnic Populations by GUMBO, Tawanda, LOUIE, Arnold, WEIGUO LIU, BROWN, David, AMBROSE, Paul G, BHAVNANI, Sujata M, DRUSANO, George L

    Published in Antimicrobial Agents and Chemotherapy (01-07-2007)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  18. 18
  19. 19
  20. 20

    Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia by Rubino, Christopher M, Bhavnani, Sujata M, Forrest, Alan, Dukart, Gary, Dartois, Nathalie, Cooper, Angel, Korth-Bradley, Joan, Ambrose, Paul G

    “…Exposure-response analyses for efficacy and safety were performed for tigecycline-treated patients suffering from community-acquired pneumonia. Data were…”
    Get full text
    Journal Article